Short Interest in Teleflex Incorporated (NYSE:TFX) Declines By 17.1%

Teleflex Incorporated (NYSE:TFXGet Free Report) saw a large drop in short interest in April. As of April 30th, there was short interest totalling 590,300 shares, a drop of 17.1% from the April 15th total of 712,200 shares. Based on an average trading volume of 321,800 shares, the short-interest ratio is presently 1.8 days.

Teleflex Stock Performance

TFX stock traded up $3.30 during mid-day trading on Monday, reaching $207.23. 214,627 shares of the stock traded hands, compared to its average volume of 289,265. The company has a quick ratio of 1.41, a current ratio of 2.51 and a debt-to-equity ratio of 0.37. The business has a 50-day moving average of $215.01 and a two-hundred day moving average of $226.81. The firm has a market capitalization of $9.76 billion, a PE ratio of 32.73, a P/E/G ratio of 1.97 and a beta of 1.13. Teleflex has a 52 week low of $177.63 and a 52 week high of $262.97.

Teleflex (NYSE:TFXGet Free Report) last released its earnings results on Thursday, May 2nd. The medical technology company reported $3.21 EPS for the quarter, beating the consensus estimate of $3.07 by $0.14. The firm had revenue of $737.80 million during the quarter, compared to analysts’ expectations of $726.85 million. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The business’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same period in the prior year, the company earned $3.09 EPS. As a group, equities analysts predict that Teleflex will post 13.75 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Wednesday, May 15th will be given a $0.34 dividend. The ex-dividend date is Tuesday, May 14th. This represents a $1.36 annualized dividend and a yield of 0.66%. Teleflex’s dividend payout ratio (DPR) is currently 21.83%.

Insiders Place Their Bets

In other news, VP Cameron P. Hicks sold 7,401 shares of the stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the transaction, the vice president now owns 10,050 shares of the company’s stock, valued at $2,261,250. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.43% of the stock is owned by company insiders.

Institutional Investors Weigh In On Teleflex

A number of institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. lifted its holdings in shares of Teleflex by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock worth $1,255,408,000 after acquiring an additional 96,711 shares during the period. Mitsubishi UFJ Trust & Banking Corp lifted its stake in Teleflex by 5.7% during the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 26,140 shares of the medical technology company’s stock worth $5,912,000 after purchasing an additional 1,412 shares during the period. SageView Advisory Group LLC acquired a new stake in Teleflex during the first quarter valued at approximately $354,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Teleflex by 22.1% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 56,461 shares of the medical technology company’s stock valued at $12,770,000 after purchasing an additional 10,203 shares during the period. Finally, State Board of Administration of Florida Retirement System raised its holdings in shares of Teleflex by 3.6% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 51,679 shares of the medical technology company’s stock worth $11,688,000 after buying an additional 1,790 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. JMP Securities restated a “market outperform” rating and issued a $285.00 price target on shares of Teleflex in a research report on Friday, February 23rd. Royal Bank of Canada cut their target price on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. Truist Financial lowered their target price on Teleflex from $240.00 to $219.00 and set a “hold” rating for the company in a report on Friday, May 3rd. StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Finally, Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Friday, May 3rd. Four analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $261.75.

View Our Latest Stock Analysis on Teleflex

Teleflex Company Profile

(Get Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

See Also

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.